Serum soluble interleukin-2 receptor (IL-2R) in children with allergic disorders. 1993

S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
Department of Pediatrics, University of Brescia, Italy.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007223 Infant A child between 1 and 23 months of age. Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004485 Eczema A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents. Dermatitis, Eczematous,Eczematous Dermatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors

Related Publications

S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
December 1994, Journal of endocrinological investigation,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
October 2002, International journal of clinical oncology,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 1990, The Journal of nuclear medicine and allied sciences,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 2004, Roczniki Akademii Medycznej w Bialymstoku (1995),
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 1991, European cytokine network,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 1996, Oncology reports,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
September 1992, Pharmacological research,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 1990, Zeitschrift fur Rheumatologie,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
May 2012, Pediatric transplantation,
S Guarnaccia, and C C Kurman, and L D Notarangelo, and S La Grutta, and F Candotti, and A G Ugazio, and D L Nelson, and J A Bellanti
January 1993, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Copied contents to your clipboard!